- Home
- GOSS vs LFVN Comparison
GOSS vs LFVN Comparison
Compare GOSS & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- LFVN
- Stock Information
- Founded
- GOSS 2015
- LFVN N/A
- Country
- GOSS United States
- LFVN United States
- Employees
- GOSS N/A
- LFVN N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- GOSS Health Care
- LFVN Health Care
- Exchange
- GOSS Nasdaq
- LFVN Nasdaq
- Market Cap
- GOSS 203.3M
- LFVN 165.9M
- IPO Year
- GOSS 2019
- LFVN N/A
- Fundamental
- Price
- GOSS $1.16
- LFVN $12.63
- Analyst Decision
- GOSS Strong Buy
- LFVN Strong Buy
- Analyst Count
- GOSS 4
- LFVN 2
- Target Price
- GOSS $7.75
- LFVN $30.50
- AVG Volume (30 Days)
- GOSS 1.6M
- LFVN 215.9K
- Earning Date
- GOSS 05-15-2025
- LFVN 05-06-2025
- Dividend Yield
- GOSS N/A
- LFVN 1.38%
- EPS Growth
- GOSS N/A
- LFVN 152.87
- EPS
- GOSS N/A
- LFVN 0.70
- Revenue
- GOSS $124,590,000.00
- LFVN $222,347,000.00
- Revenue This Year
- GOSS N/A
- LFVN $17.36
- Revenue Next Year
- GOSS $190.37
- LFVN $9.60
- P/E Ratio
- GOSS N/A
- LFVN $18.62
- Revenue Growth
- GOSS N/A
- LFVN 8.22
- 52 Week Low
- GOSS $0.50
- LFVN $5.22
- 52 Week High
- GOSS $1.55
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- GOSS 55.35
- LFVN 46.77
- Support Level
- GOSS $1.09
- LFVN $12.07
- Resistance Level
- GOSS $1.20
- LFVN $13.13
- Average True Range (ATR)
- GOSS 0.09
- LFVN 0.64
- MACD
- GOSS 0.00
- LFVN 0.09
- Stochastic Oscillator
- GOSS 69.01
- LFVN 43.07
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.